Health Trials

Glofitamab

2

Review clinical trials related to Glofitamab. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

to learn if giving glofitamab after treatment with BTKi-rituximab can help to control high-risk MCL.

Participants needed: 30
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: May 20, 2026Locations: 1
Eligibility criteria

Confirmed diagnosis of mantle cell lymphoma by hematopathology. MCL should have... [+3]

Isolated bone marrow or GI only disease MCL participants and/or lack of any meas... [+43]

Read more
Status: Not yet recruiting

Gut Microbiome in DLBCL Treated With Glofitamab

The gut microbiome (GM) has recently emerged as one of the key modifiable factors of response and prognosis to immunotherapy in cancer patients. Currently, it is unknown if GM also modulates anti-tumor responses to T cell engagers (TCE) including glofitamab in DLBCL patients.

Participants needed: 30
Trial details
Biological sex: AllType: ObservationalSponsor: Peking Union Medical College HospitalUpdated: Mar 27, 2026
Eligibility criteria

Histologically/cytologically confirmed diagnosis of DLBCL [+2]

Evidence of significant, uncontrolled concomitant diseases that could affect com... [+1]

Read more